Z-1403-2022 Class II Terminated

Recalled by RAYSEARCH LABORATORIES AB — Stockholm, N/A

FDA device recall Z-1403-2022 was initiated by RAYSEARCH LABORATORIES AB on Jun 1, 2022 and is designated Class II. Reason for recall: An issue with propagation of treatment course information from RayStation with RayTreat to RayCare has been identified. During some workflows, information may not be propagated to RayCare. The recall status is terminated (terminated Oct 4, 2023). Affected quantity: 1.

Recall Details

Product Type
Devices
Report Date
Jul 27, 2022
Initiation Date
Jun 1, 2022
Termination Date
Oct 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1

Product Description

RayStation 9B SP1. For radiation treatment planning.

Reason for Recall

An issue with propagation of treatment course information from RayStation with RayTreat to RayCare has been identified. During some workflows, information may not be propagated to RayCare.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the state of TN and the countries of Belgium and Switzerland.

Code Information

UDI-DI: 0735000201029720200310 Build number 9.2.0.483

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1403-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.